Total Payments
$3,636
2024 Payments
$1,049
Companies
32
Transactions
176
Medicare Patients
1,430
Medicare Billing
$170,429
Payment Breakdown by Category
Food & Beverage$3,496 (96.1%)
Education$140.09 (3.9%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,496 | 174 | 96.1% |
| Education | $140.09 | 2 | 3.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $589.72 | 32 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $480.18 | 21 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $390.30 | 18 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $293.25 | 14 | $0 (2024) |
| Harmony Biosciences Llc | $268.38 | 10 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $238.29 | 14 | $0 (2024) |
| Merck Sharp & Dohme LLC | $169.77 | 9 | $0 (2024) |
| Axsome Therapeutics, Inc. | $141.55 | 5 | $0 (2024) |
| Kiniksa Pharmaceuticals, Ltd. | $107.82 | 6 | $0 (2023) |
| Alnylam Pharmaceuticals Inc. | $95.23 | 4 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,049 | 50 | Boehringer Ingelheim Pharmaceuticals, Inc. ($138.02) |
| 2023 | $1,074 | 49 | E.R. Squibb & Sons, L.L.C. ($237.31) |
| 2022 | $1,081 | 52 | Janssen Pharmaceuticals, Inc ($234.73) |
| 2021 | $379.35 | 21 | Amgen Inc. ($158.73) |
| 2019 | $10.96 | 1 | GlaxoSmithKline, LLC. ($10.96) |
| 2018 | $30.39 | 2 | GlaxoSmithKline, LLC. ($18.30) |
| 2017 | $10.49 | 1 | GlaxoSmithKline, LLC. ($10.49) |
All Payment Transactions
176 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $26.25 | General |
| Category: Cardiovascular | ||||||
| 12/13/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $25.02 | General |
| Category: CARDIOVASCULAR | ||||||
| 12/10/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $21.90 | General |
| Category: Cardiovascular | ||||||
| 11/18/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $17.10 | General |
| Category: DIABETES | ||||||
| 11/15/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $19.39 | General |
| Category: Cardiology | ||||||
| 11/13/2024 | AltaThera Pharmaceuticals LLC | Sotalol Hydrochloride (Drug) | Food and Beverage | Cash or cash equivalent | $6.70 | General |
| Category: Cardiovascular | ||||||
| 11/12/2024 | Alnylam Pharmaceuticals Inc. | ONPATTRO (Drug) | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: Genetic Disease | ||||||
| 11/11/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $28.80 | General |
| Category: Respiratory | ||||||
| 11/06/2024 | SCPHARMACEUTICALS INC. | FUROSCIX (Drug) | Food and Beverage | In-kind items and services | $22.67 | General |
| Category: Cardiology | ||||||
| 10/28/2024 | AstraZeneca Pharmaceuticals LP | WAINUA (Drug) | Food and Beverage | In-kind items and services | $13.87 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/23/2024 | Amgen Inc. | — | Food and Beverage | In-kind items and services | $17.35 | General |
| 10/16/2024 | Alnylam Pharmaceuticals Inc. | ONPATTRO (Drug) | Food and Beverage | In-kind items and services | $24.96 | General |
| Category: Genetic Disease | ||||||
| 10/07/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $25.39 | General |
| Category: DIABETES | ||||||
| 10/03/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $19.89 | General |
| Category: Obesity | ||||||
| 09/25/2024 | Harmony Biosciences Llc | WAKIX (Drug) | Food and Beverage | Cash or cash equivalent | $29.07 | General |
| Category: Narcoplepsy | ||||||
| 09/25/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $13.58 | General |
| Category: Cardiovascular | ||||||
| 09/23/2024 | United Therapeutics Corporation | — | Food and Beverage | In-kind items and services | $20.88 | General |
| 09/18/2024 | Alnylam Pharmaceuticals Inc. | ONPATTRO (Drug) | Food and Beverage | In-kind items and services | $20.28 | General |
| Category: Genetic Disease | ||||||
| 09/16/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $15.87 | General |
| Category: DIABETES | ||||||
| 08/30/2024 | CARDIVA MEDICAL, INC. | SAVVYWIRE (Device) | Food and Beverage | In-kind items and services | $25.89 | General |
| Category: DEVICES | ||||||
| 08/28/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $15.37 | General |
| 08/05/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $29.96 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 07/12/2024 | CARDIVA MEDICAL, INC. | OPTOWIRE (Device) | Food and Beverage | In-kind items and services | $32.23 | General |
| Category: DEVICES | ||||||
| 06/16/2024 | HEARTFLOW, INC. | FFRct (Device) | Food and Beverage | Cash or cash equivalent | $35.79 | General |
| Category: Coronary | ||||||
| 06/14/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $15.73 | General |
| Category: Cardiology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 501 | 563 | $196,404 | $62,039 |
| 2022 | 5 | 382 | 425 | $151,942 | $51,090 |
| 2021 | 4 | 235 | 263 | $99,238 | $35,306 |
| 2020 | 2 | 312 | 320 | $59,708 | $21,994 |
Total Patients
1,430
Total Services
1,571
Medicare Billing
$170,429
Procedure Codes
17
All Medicare Procedures & Services
17 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 262 | 313 | $92,561 | $30,018 | 32.4% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 92 | 92 | $47,012 | $15,036 | 32.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 82 | 90 | $38,517 | $11,860 | 30.8% |
| 95806 | Sleep study including heart rate, breathing, airflow, and effort | Office | 2023 | 30 | 31 | $9,750 | $2,236 | 22.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 24 | 25 | $5,184 | $1,839 | 35.5% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2023 | 11 | 12 | $3,380 | $1,050 | 31.1% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 129 | 129 | $65,570 | $21,425 | 32.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 142 | 175 | $49,032 | $17,156 | 35.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 48 | 48 | $19,856 | $7,128 | 35.9% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2022 | 29 | 31 | $6,434 | $2,843 | 44.2% |
| 95806 | Sleep study including heart rate, breathing, airflow, and effort | Office | 2022 | 34 | 42 | $11,050 | $2,538 | 23.0% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 109 | 109 | $55,154 | $19,542 | 35.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 68 | 88 | $23,232 | $9,533 | 41.0% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 26 | 26 | $10,452 | $3,571 | 34.2% |
| 95806 | Unattended sleep study with recording of heart rate, oxygen, respiratory airflow and effort | Office | 2021 | 32 | 40 | $10,400 | $2,660 | 25.6% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 251 | 259 | $42,994 | $16,320 | 38.0% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 61 | 61 | $16,714 | $5,674 | 33.9% |
About Dr. Robert Ajello, MD
Dr. Robert Ajello, MD is a Internal Medicine healthcare provider based in Greenfield, Massachusetts. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/08/2006. The National Provider Identifier (NPI) number assigned to this provider is 1518930916.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robert Ajello, MD has received a total of $3,636 in payments from pharmaceutical and medical device companies, with $1,049 received in 2024. These payments were reported across 176 transactions from 32 companies. The most common payment nature is "Food and Beverage" ($3,496).
As a Medicare-enrolled provider, Ajello has provided services to 1,430 Medicare beneficiaries, totaling 1,571 services with total Medicare billing of $170,429. Data is available for 4 years (2020–2023), covering 17 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Critical Care Medicine, Sleep Medicine
- Location Greenfield, MA
- Active Since 02/08/2006
- Last Updated 12/22/2017
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1518930916
Products in Payments
- Repatha (Biological) $572.37
- XARELTO (Drug) $480.18
- ELIQUIS (Drug) $237.21
- Wakix (Drug) $219.12
- JARDIANCE (Drug) $205.74
- CAMZYOS (Drug) $150.08
- Sunosi (Drug) $141.55
- VERQUVO (Drug) $110.76
- Arcalyst (Drug) $95.70
- ONPATTRO (Drug) $95.23
- VYNDAQEL (Drug) $69.50
- OFEV (Drug) $69.32
- Inpefa (Drug) $66.21
- BELSOMRA (Drug) $59.01
- DUPIXENT (Biological) $51.44
- FARXIGA (Drug) $50.35
- FUROSCIX (Drug) $49.30
- WAKIX (Drug) $49.26
- TRELEGY ELLIPTA (Drug) $48.42
- Ozempic (Drug) $41.05
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Greenfield
Kerri Kissell, Md, MD
Internal Medicine — Payments: $117,132
Internal Medicine $117,132
Dr. Shreekant Vasudhev, Md, MD
Internal Medicine — Payments: $69,827
Internal Medicine $69,827
Robert Klinestiver, Md, MD
Internal Medicine — Payments: $11,924
Internal Medicine $11,924
Bryce Lynn, Md, MD
Internal Medicine — Payments: $9,100
Internal Medicine $9,100
Dr. Heba Wassif, Md, MD
Internal Medicine — Payments: $7,256
Internal Medicine $7,256
Hiroko Noda-Heiny, Md, MD
Internal Medicine — Payments: $2,161
Internal Medicine $2,161